Creutzfeldt-Jakob
Would you like to receive a message when there is new research on Creutzfeldt-Jakob? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll receive a message as soon as there is new research on Creutzfeldt-Jakob. View what Premium costs.
Publications and studies (1022)
- Commentary or editorialiAn expert's opinion or commentary, not new research. Detection of Prion Protein Seeding Activity in Tear Fluids. (2023/05/11) ♡
- Unexpected decrease of full-length prion protein in macaques inoculated with prion-contaminated blood products. (2023/05/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Risk assessment of variant Creutzfeldt-Jakob disease in corneal transplantation. (2023/05/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Design and application of a customizable relational DataBase to assess clinicopathological correlations and concomitant pathology in neurodegenerative diseases. (2023/05/01) ♡
- Clinical and Genetic Characteristics of the Heidenhain Variant of Creutzfeldt-Jakob Disease. (2023/04/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease. (2023/04/01) ♡
- Right Brain: The Purple Scarf and the Cortical Ribbon. (2023/03/14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia. (2023/02/15) ♡
- Blood donor notification of variant Creutzfeldt-Jakob disease risk: Lessons in communicating donor deferral and risk. (2023/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Functional neurological symptoms as initial presentation of Creutzfeldt-Jakob disease: case series. (2023/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Presence of anti-IgLON5 antibody in a case of sporadic Creutzfeldt-Jakob disease with sleep disturbance as a prominent symptom. (2023/02/01) ♡
- Kinetics of the reduction of Creutzfeldt-Jakob disease prion seeding activity by steam sterilization support the use of validated 134°C programmes. (2023/02/01) ♡
- Sporadic Creutzfeldt-Jakob Disease in the young (50 and below): 10-year review of United Kingdom surveillance. (2023/02/01) ♡
- Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy. (2023/02/01) ♡
- Effects of the pathological E200K mutation on human prion protein: A computational screening and molecular dynamics approach. (2023/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A review article on neuroprotective, immunomodulatory, and anti-inflammatory role of vitamin-D3 in elderly COVID-19 patients. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Creutzfeldt-Jakob disease in a post-COVID-19 patient: did SARS-CoV-2 accelerate the neurodegeneration? (2023/01/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Blood Neurofilament Light Chain in Different Types of Dementia. (2023/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Natural History Study of Preclinical Genetic Creutzfeldt-Jakob Disease (CJD) (2023-02-28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prion Mutations in Republic of Korea, China, and Japan. (2022/12/30) ♡
- Silence of resident microglia in GPI anchorless prion disease and activation of microglia in Gerstmann-Sträussler-Scheinker disease and sporadic Creutzfeldt-Jakob disease. (2022/12/19) ♡
- Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease. (2022/12/14) ♡
- Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases. (2022/12/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rapidly Progressive Frontotemporal Dementia With Amyotrophic Lateral Sclerosis in an Elderly Female. (2022/12/04) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systematic Review of Clinical and Pathophysiological Features of Genetic Creutzfeldt-Jakob Disease Caused by a Val-to-Ile Mutation at Codon 180 in the Prion Protein Gene. (2022/12/02) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Sporadic Creutzfeldt-Jakob disease as a mimic of progressive supranuclear palsy. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. 18F-FP-CIT PET/CT in a case of probable sporadic Creutzfeldt-Jakob disease with parkinsonism as initial symptom. (2022/12/01) ♡
- Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study. (2022/12/01) ♡
- A novel clinicopathologic entity causing rapidly progressive cerebellar ataxia? (2022/12/01) ♡
- Improving Early Recognition of Creutzfeldt-Jakob Disease Mimics. (2022/12/01) ♡
- Identification of a Cardiac Glycoside Exhibiting Favorable Brain Bioavailability and Potency for Reducing Levels of the Cellular Prion Protein. (2022/11/26) ♡
- Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer's and other neurodegenerative diseases. (2022/11/22) ♡
- M(1) muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. (2022/11/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Three Case Reports of Rapidly Progressive Dementias and Narrative Review. (2022/11/11) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Creutzfeldt-Jakob Disease: A Case Report and Literature Review for Understanding the Big Picture. (2022/11/09) ♡
- A longitudinal (18)F-FDG PET/MRI study in asymptomatic stage of genetic Creutzfeldt-Jakob disease linked to G114V mutation. (2022/11/01) ♡
- Genetic Creutzfeldt-Jakob disease in Turkish Jews-demographic and clinical features. (2022/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Redox stress and metal dys-homeostasis appear as hallmarks of early prion disease pathogenesis in mice. (2022/11/01) ♡
- Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. (2022/11/01) ♡
- Contrast media mimicking subarachnoid hemorrhage after intrathecal injection in a patient with Creutzfeldt-Jakob disease. (2022/11/01) ♡
- Stress and viral insults do not trigger E200K PrP conversion in human cerebral organoids. (2022/10/27) ♡
- Chronological Changes in the Expression Pattern of Hippocampal Prion Proteins During Disease Progression in Sporadic Creutzfeldt-Jakob Disease MM1 Subtype. (2022/10/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Propagation of Diffusion-Weighted MRI Abnormalities in the Preclinical Stage of Sporadic Creutzfeldt-Jakob Disease. (2022/10/18) ♡
- Amino Acid Substitution within Seven-Octapeptide Repeat Insertions in the Prion Protein Gene Associated with Short-Term Course. (2022/10/13) ♡
- Glycans are not necessary to maintain the pathobiological features of bovine spongiform encephalopathy. (2022/10/07) ♡
- Cortical Signal Changes in Creutzfeldt-Jakob Disease. (2022/10/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Genetic aspects of human prion diseases. (2022/10/05) ♡
- Translatome profiling in fatal familial insomnia implicates TOR signaling in somatostatin neurons. (2022/10/03) ♡
- Estimation of the number of inherited prion disease mutation carriers in the UK. (2022/10/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.